Form 8-K - Current report:
SEC Accession No. 0001493152-24-032831
Filing Date
2024-08-16
Accepted
2024-08-16 16:30:15
Documents
14
Period of Report
2024-08-13
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 45154
2 ex99-1.htm EX-99.1 25399
  Complete submission text file 0001493152-24-032831.txt   250934

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE ogen-20240813.xsd EX-101.SCH 3018
4 XBRL LABEL FILE ogen-20240813_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE ogen-20240813_pre.xml EX-101.PRE 22361
16 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3659
Mailing Address 1990 MAIN STREET SUITE 750 SARASOTA FL 34236
Business Address 1990 MAIN STREET SUITE 750 SARASOTA FL 34236 8132867900
ORAGENICS INC (Filer) CIK: 0001174940 (see all company filings)

EIN.: 593410522 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32188 | Film No.: 241217093
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)